地产分类指数续升逾3% 润地涨8%逼近高位 长实及领展分别越百天及牛熊线
环球新冠疫苗研发露曙光,辉瑞与德国药厂BioNTech研发新冠肺炎疫苗於人体试验中有效预防率超过九成远胜预期。此外,内地10月百强房企首十个月销售额均值逼近千亿人民币,按年增长12.3%至994.9亿人民币。市场资金继续由新经济股转移至旧经济股,地产分类指数连续第二天急升,午後高见34,878,现造34,728,续升3.3%。
10只成份股除昨天飙升14%九仓置业(01997.HK)反覆高见40.25元创逾八个月高无以为继回吐2.2%报38.4元外,全部续涨1.7%-7.7%。上月总合同销售额按年升3.5%至260.4亿人民币润地(01109.HK)升幅最大,股价五连升兼突破9月所创近期高位38.45元,最高见39.15元,暂受制1月初所创纪录高位40.45元,现造39.1元,续涨7.9%,成交增至1,494万股。
获联席主席杨惠妍於上月29日至本月5日连续6天共增持1.16亿股的碧桂园(02007.HK)三连涨,最高见11.44元创逾九个月高,现造11.26元,续升1.8%。中国海外(00688.HK)高见21.7元,暂受制百天线(22.2元),现造21.5元,续升3.1%。
新地(00016.HK)及长实集团(01113.HK)分别升破牛熊线及百天线(104.5元及41.8元),最高见107.5元及42.55元,现造106.9元及42.4元,续升2.8%及3.9%;恒地(00012.HK)及新世界(00017.HK)续升2%及3%,分别高见31.5元及41元,创逾4个月及2个月高。
获麦格理升价71.2元的领展(00823.HK)重越牛熊线(69.4元),最高见70元,现造69.5元,续升3%。恒隆地产(00101.HK)高见21.35元,创逾两个月高,现造21.15,续升1.7%。
另外,非地产分类成份股太古A(00019.HK)更续涨9%报44.4元,创逾四个月高,表现为最强蓝筹。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.